Acquisition Opportunity RxS has been acquired by Medvantx, expanding potential cross-sell opportunities into Medvantx’s direct-to-patient and pharmacy services. Leverage the combined capabilities to reposition RxS’s sample management platform as a strategic integration within Medvantx’s broader healthcare ecosystem.

Multi-Channel Expansion RxS offers end-to-end multi-channel sample management including rep hand carry, direct to practitioner, and direct to consumer. This positions for upsell with pharmaceutical brands seeking unified field and patient engagement, as well as healthcare providers requiring seamless sample distribution and analytics.

Technology Driven Strong tech stack (Power BI, SQL Server, Google/LinkedIn Ads, Hotjar, SharePoint) enables data-driven decision support. Market to brands emphasizing analytics, performance visibility, and channel attribution in their sampling programs.

Compliance and Expertise Leadership with manufacturing and vendor experience, plus a woman-owned, healthcare-focused ethos. Use this to approach mid-market pharma companies seeking trusted partners with practical regulatory and operational know-how.

Growth Through Kentucky Expansion Medvantx’s recent Kentucky expansion and capacity increases signal scale readiness and a broader distribution network. Target opportunities around supply chain resilience, cold-chain fulfillment, and nationwide sampling and medication distribution collaborations.